Dr. med. Mike Mendelson
Dr. med. Mike Mendelson

Dr. med. Mike Mendelson

Director, Cardiovascular & Metabolism, Translational Medicine, Novartis Biomedical Research

Dr. Mike Mendelson joined the Novartis Institutes for Biomedical Research (NIBR) in 2019, leading early clinical development programs in arrhythmia and cardiovascular rare disease indications. He is currently the cardio-immunology early clinical development program lead. Prior to joining Novartis, he was a cardiologist at Boston Children's Hospital with a clinical focus in pediatric preventive cardiology and a research focus in population genomics. He completed research training with the U.S. NIH/NHLBI, Boston University, and Harvard School of Public Health and clinical training at Boston Children’s Hospital/Harvard Medical School, SickKids Hospital/University of Toronto, and Montreal Children’s Hospital/McGill University.